Vaccination

UK orders 60m Pfizer vaccine doses for booster programme

Britain on Wednesday announced that it had ordered 60 million more doses of the Pfizer/BioNtech coronavirus vaccine for a booster programme aimed at protecting the most vulnerable during winter.

Vaccination

Pfizer defends high cost of COVID vaccine

The head of Pfizer said Thursday the company's COVID vaccine, among the priciest on the market, is no more expensive than the cost of a meal and will not be sold to poor countries for a profit.

Vaccination

EU turns to BioNTech/Pfizer after J&J vaccine suspension

The EU is turning more heavily to BioNTech/Pfizer to make up for suspended Johnson & Johnson vaccine doses and for longer-term needs to fight the mutating coronavirus, its chief Ursula von der Leyen said Wednesday.

Vaccination

The Pfizer/BioNTech vaccine bet that paid off

With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their COVID vaccine at a brisk pace and relatively free of controversy.

page 20 from 40